VIM
EW icon

Vinva Investment Management’s Edwards Lifesciences EW Stock Holding History

Vinva Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,027
Closed -$718K – 491
2026
Q1 		$718K Buy
9,027
+5,792
+179% +$478K 0.01% 366
2025
Q4 		$279K Buy
+3,235
New +$265K ﹤0.01% 379
2024
Q4 		– Sell
-10,011
Closed -$667K – 423
2024
Q3 		$667K Sell
10,011
-15,135
-60% -$1.1M 0.03% 345
2024
Q2 		$2.35M Buy
25,146
+1,417
+6% +$125K 0.12% 188
2024
Q1 		$2.27M Buy
23,729
+784
+3% +$65.9K 0.13% 190
2023
Q4 		$1.76M Buy
22,945
+3,641
+19% +$253K 0.12% 190
2023
Q3 		$1.35M Buy
19,304
+106
+0.6% +$8.52K 0.13% 168
2023
Q2 		$1.77M Sell
19,198
-1,651
-8% -$143K 0.15% 160
2023
Q1 		$1.7M Buy
+20,849
New +$1.64M 0.14% 167

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vinva Investment Management's EW Position: Q2 2026 in Review

Vinva Investment Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 9,027 shares — an estimated $718K sold.

Vinva Investment Management first reported a position in EW in Q1 2023 and held it in 9 quarters. The position peaked at $2.35M in Q2 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vinva Investment Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Vinva Investment Management sold 9,027 Edwards Lifesciences shares in Q2 2026, an estimated $718K.
  • Vinva Investment Management first reported a position in Edwards Lifesciences in Q1 2023 and held it in 9 quarters.
  • Vinva Investment Management's Edwards Lifesciences position peaked at $2.35M in Q2 2024.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.